The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin

The Journal of Infectious Diseases
J Renneberg, M Walder

Abstract

Beta-lactamase-producing Staphylococcus aureus and Bacteroides fragilis in a localized mixed infection has been found to degrade the beta-lactam antibiotic at the focus of infection, thus protecting both the bacteria and pathogens susceptible to the antibiotic. To determine if beta-lactamase produced by Hemophilus influenzae and Branhamella catarrhalis have similar importance in mixed infections, a thread infection model in mice was used to evaluate the capacity of beta-lactamase produced by S. aureus, B. catarrhalis, or H. influenzae to hydrolyze ampicillin in a mixed infection with Streptococcus pneumoniae in mice. For both S. aureus and B. catarrhalis, the ampicillin concentrations at infection sites where beta-lactamase was produced were lower than at sites where beta-lactamase was not produced; however, this difference was not found when clavulanic acid was added to the ampicillin. In mixed infections with strains that did not produce beta-lactamase, ampicillin concentrations were similar with or without clavulanic acid. S. aureus was the best "protector" followed by B. catarrhalis. The beta-lactamase produced by H. influenzae failed to protect the S. pneumoniae. No bactericidal effect of clavulanic acid was found.

Citations

Nov 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J J ChristensenB Bruun
Apr 26, 2006·Expert Opinion on Emerging Drugs·Avner AliphasKenneth M Grundfast
Mar 1, 1993·World Journal of Surgery·P L ErginaJ L Meakins
Jan 27, 2021·Antimicrobial Agents and Chemotherapy·Nicholas M SmithJustin R Lenhard
Jul 1, 1992·Infection and Immunity·C BunceN Barg
Jul 11, 2021·The Journal of Antimicrobial Chemotherapy·Tiffany A McMurtryJustin R Lenhard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.